Literature DB >> 17667623

Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.

Chun-Chi Chiang1, Jane-Ming Lin, Wen-Lu Chen, Yi-Yu Tsai.   

Abstract

PURPOSE: To describe the use of allogeneic serum eye drops to treat 2 patients with chronic graft-versus-host disease (GVHD)-induced severe ocular surface disease.
METHODS: Small case series.
RESULTS: Conventional therapy failed to control the ocular symptoms of 2 patients with GVHD who presented with severe dry eye syndrome. Because autologous serum was unavailable in these cases, we used allogeneic serum eye drops as an alternate option for treating their ocular surface disease. Both donors had serologic tests performed before donation. Use of the allogeneic serum eye drops had a beneficial clinical effect, with marked attenuation of the patients' symptoms. This therapy proved to be safe during 10 months of treatment.
CONCLUSIONS: Allogeneic serum eye drops may be a good alternative treatment for patients with severe dry eyes caused by GVHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667623     DOI: 10.1097/ICO.0b013e3180645cd7

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  21 in total

1.  [Glaucoma and dry eye. Current concepts and future perspectives].

Authors:  P Steven; C Cursiefen
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

2.  Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.

Authors:  Kyung-Sun Na; Man Soo Kim
Journal:  J Ocul Pharmacol Ther       Date:  2012-06-25       Impact factor: 2.671

3.  Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting.

Authors:  J T Seki; N Sakurai; S Moldenhauer; J Dam; E G Atenafu; P M Yip; T Mazzulli; T Henderson; J Pendergrast; C Cserti; J P Velazquez; R Simpson; G Felluga; H A Messner; J H Lipton
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

4.  Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops.

Authors:  Piera Versura; Marina Buzzi; Giuseppe Giannaccare; Adriana Terzi; Michela Fresina; Claudio Velati; Emilio C Campos
Journal:  Blood Transfus       Date:  2015-07-09       Impact factor: 3.443

Review 5.  Autologous serum eye drops for dry eye.

Authors:  Qing Pan; Adla Angelina; Andrea Zambrano; Michael Marrone; Walter J Stark; Thomas Heflin; Li Tang; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2013-08-27

Review 6.  [Autologous serum and alternative blood products for the treatment of ocular surface disorders].

Authors:  G Geerling; J D Unterlauft; K Kasper; S Schrader; A Opitz; D Hartwig
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

7.  Refractory recurrent ocular graft versus host disease.

Authors:  Emily Greenan; Elisabeth Vandenberghe; Conor C Murphy
Journal:  BMJ Case Rep       Date:  2019-12-15

Review 8.  Autologous serum eye drops for dry eye.

Authors:  Qing Pan; Adla Angelina; Michael Marrone; Walter J Stark; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2017-02-28

Review 9.  Cascade of Inflammatory, Fibrotic Processes, and Stress-Induced Senescence in Chronic GVHD-Related Dry Eye Disease.

Authors:  Yoko Ogawa; Yutaka Kawakami; Kazuo Tsubota
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

Review 10.  Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis.

Authors:  Maria Rosaria De Pascale; Michele Lanza; Linda Sommese; Claudio Napoli
Journal:  J Ophthalmol       Date:  2015-10-04       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.